Company / Working Capital
Avidity Biosciences, Inc. Working Capital History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Working Capital
$1.6B
FY2025
5-year range
$381.5M / $1.6B
FY2021-FY2025
Trend
+11.0%
vs FY2024
Sector context
#27 of 213
Health Care
What the data says
Avidity Biosciences, Inc.'s working capital of $1.6B is higher than 87% of companies in the Health Care sector (FY2025). Improved from $531M to $1.6B over the past 2 years.
Based on SEC 10-K filings.
$1.6B in FY2025 with a 5-year CAGR of +38.3%. Top quartile in the Health Care sector.
Improved from $531M to $1.6B over the past 2 years.
Health Care sector context is included.
Working Capital over time
Growth rates
- 3-Year CAGR
- +41.1%
- 5-Year CAGR
- +38.3%
- 10-Year CAGR
- -
Sector benchmark
Top 13% in Health CareTop 13% of 213This company $1.6B Sector average $934.6M
▼
+71.5% above sector average
Key checks
Key Insights
- 5-year CAGR of +38.3%, indicating consistent growth.
- In FY2025, working capital increased 11.0% year-over-year.
- Ranks #27 out of 213 companies in the Health Care sector.
- Lowest working capital in the period was in FY2019.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Working CapitalValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $1.6B | +11.0% |
| FY2024 | $1.4B | +172.2% |
| FY2023 | $530.6M | -7.1% |
| FY2022 | $571.0M | +49.7% |
| FY2021 | $381.5M | +20.3% |
| FY2020 | $317.1M | +271.1% |
| FY2019 | $85.4M | - |
| FY2018 | - | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026